This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

2 - 4 November 2021
Delivered in GMT time zone

2 - 4 November 2021
Delivered in GMT time zone

Plenary: COVID-19 And The Future Clinical Trials Landscape

Leading Insights For The Whole Clinical Trials Community

Clinical Trials Europe Day 1 Plenary

Day 1: 2nd November 2020
11.00 - 17.00

11:20 - 11:40 | Changes and challenges to clinical trials during and after a worldwide pandemic

Janis Little, Vice President, Global R&D Quality, Allergan, USA

11:40 - 12:00 | Biotech experience of the rapid and nimble acceleration of clinical programmes in the light of SARS CoV2

Elizabeth Eagling-Vose, Director, Head of Clinical Operations, Vaccitech, UK 

12:00 - 12:20 | Vaccine acceptability

Robert Dingwall, Professor of Sociology, Nottingham Trent University, UK 

12:20 - 12:50 | Live Q&A with Plenary Speakers

Janis Little, Vice President, Global R&D Quality, AllerganUSA

Elizabeth Eagling-VoseDirector, Head of Clinical Operations, Vaccitech, UK

Robert Dingwall, Professor of Sociology, Nottingham Trent University, UK

12:50 - 13:50 | Networking Forum and Exhibitor “Meet and Greet”

Take this time to grab some refreshments, connect with colleagues, browse the virtual exhibition hall and meet with fellow attendees.

13:50 - 14:10 | Change of operational model during COVID-19 pandemic

Bodo Lutz, Clinical Risk Management and Data Integrity QA, Novartis, Germany

14:10 - 14:30 | Spotlight Presentation: Effects of an unpredictable pandemic on clinical trials and the need for virtualization

Anthony Costello, Senior Vice President, Medidata, USA


14:30 - 15:00 | Live Q&A with Plenary Speakers

Bodo Lutz, Clinical Risk Management and Data Integrity QA, Novartis, Germany

Anthony Costello, Senior Vice President, Medidata, USA

15:00 - 16:00 | Networking Forum and Exhibitor "Meet and Greet"

16:00 - 17:00 | LIVE Virtual Networking Reception

Clinical Trials Europe Day 3 Plenary

Day 3: 4th November 2020
12:40 - 17:10

12:50 - 13:10 | The drug development paradigm and ways that the pandemic is facilitating major change

Kenneth Getz, Deputy Director and Professor, Tufts Center for the Study of Drug Development Tufts University, USA

13:10 - 13:30 | BREXIT – What impact will this have on clinical trials in the UK?

Sheuli Porkess, Executive Director Research Medical & Innovation, Association of the British Pharmaceutical Industry (ABPI), UK

13:30 - 13:50 | PANEL: The future of clinical trials

Anita Nelson, Senior Vice President, Translational Medicine, Parexel International, UK

13:50 - 14:20 | Live Q&A with Plenary Speakers

Kenneth Getz, Deputy Director and Professor, Tufts Center for the Study of Drug Development Tufts University, USA

Sheuli Porkess, Executive Director Research Medical & Innovation, Association of the British Pharmaceutical Industry (ABPI), UK

Anita Nelson, Senior Vice President, Translational Medicine, Parexel International, UK

14:20 - 15:20 | Networking Forum and Exhibitor “Meet and Greet”

15:20 - 15:30 | Christine Pierre Lifetime Achievement Award in Association with mdgroup

15:30 - 15:40 | Clinical Trials Europe Virtual Exhibition Stand Award Sponsored by PharmaTargeting

15:40 - 16:10 | Inspirational Speaker: Medical Aspects of Space travel

André Kuipers, Astronaut, Physician and Ambassador of the Earth, The Netherlands

16:10 - 17:10 | LIVE Virtual Networking Reception